Tirzepatide- A novel therapeutic against metabolic dysfunction-associated steatotic liver disease (MASLD)
Peer-Reviewed Publication Compuscript Ltd FacebookXLinkedInWeChatBlueskyMessageWhatsAppEmail image: Effect of tirzepatide treatment on body weight (A) and liver weight (B) in mice with MASLD. Representative images of liver appearance (C), histological analysis via hematoxylin‒eosin (HE) staining (D), and lipid accumulation assessment via Oil Red O staining (E) are shown. (F) HepG2 cells were incubated with 0.2% BSA, 0.2 mM PA, or 0.2 mM PA supplemented with […]
